LogicBio Therapeutics, Inc.
Alexion Pharmaceuticals, Inc. is dedicated to transforming the lives of people affected by rare diseases through continuous innovation and meaningful value creation. As part of AstraZeneca, they focus on developing breakthrough therapies, advancing science, and improving health equity for the rare disease community worldwide.
Industries
Nr. of Employees
medium (51-250)
LogicBio Therapeutics, Inc.
Foster City, California, United States, North America
Services
Clinical trials and patient engagement
Design and conduct of clinical trials for rare diseases with integrated patient engagement, patient-focused metrics and global trial execution.
Managed access (expanded access) program
Case-by-case managed access service for patients who have exhausted treatment options and cannot join clinical trials, assessed against clinical, regulatory and supply criteria.
Discovery partnerships and external collaboration
Partnership intake, evaluation and collaboration support for preclinical translation, target validation, biomarker development and technology advancement.
Externally sponsored research support (ISR/ESC)
Administrative and scientific support pathways for investigator-sponsored research and externally sponsored collaborations, including submission portals and investigator guides.
Grants and charitable foundation programs
Grantmaking and charitable funding for medical education, patient advocacy, local needs and emergency response through a centralized foundation program.
Clinical trials and patient engagement
Design and conduct of clinical trials for rare diseases with integrated patient engagement, patient-focused metrics and global trial execution.
Managed access (expanded access) program
Case-by-case managed access service for patients who have exhausted treatment options and cannot join clinical trials, assessed against clinical, regulatory and supply criteria.
Discovery partnerships and external collaboration
Partnership intake, evaluation and collaboration support for preclinical translation, target validation, biomarker development and technology advancement.
Externally sponsored research support (ISR/ESC)
Administrative and scientific support pathways for investigator-sponsored research and externally sponsored collaborations, including submission portals and investigator guides.
Grants and charitable foundation programs
Grantmaking and charitable funding for medical education, patient advocacy, local needs and emergency response through a centralized foundation program.
Expertise Areas
- Rare disease research and development
- Clinical trial management and patient-centric design
- Genomics and diagnostic development
- Data science, AI and digital health
Key Technologies
- Artificial intelligence / machine learning
- Next-generation sequencing (NGS)
- Digital health platforms
- Data analytics and web analytics